Philip S. Schein

8.4k total citations · 1 hit paper
179 papers, 6.5k citations indexed

About

Philip S. Schein is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Philip S. Schein has authored 179 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 56 papers in Molecular Biology and 32 papers in Surgery. Recurrent topics in Philip S. Schein's work include Cancer therapeutics and mechanisms (20 papers), Cancer Treatment and Pharmacology (16 papers) and Neuroendocrine Tumor Research Advances (15 papers). Philip S. Schein is often cited by papers focused on Cancer therapeutics and mechanisms (20 papers), Cancer Treatment and Pharmacology (16 papers) and Neuroendocrine Tumor Research Advances (15 papers). Philip S. Schein collaborates with scholars based in United States, United Kingdom and Malaysia. Philip S. Schein's co-authors include Vincent T. DeVita, Bruce A. Chabner, Paul V. Woolley, David A. Cooney, Frederick P. Smith, John S. Macdonald, Tom Anderson, Aquilur Rahman, Robert C. Young and Mary G. McMenamin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Philip S. Schein

171 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE

1975 368 citations Bruce A. Chabner, Philip S. Schein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip S. Schein United States	48	2.4k	1.5k	1.2k	1.2k	1.2k	179	6.5k
Morton K. Schwartz United States	47	2.1k 0.9×	1.6k 1.0×	769 0.6×	635 0.5×	1.7k 1.4×	172	6.6k
E Frei United States	42	2.2k 0.9×	1.8k 1.2×	492 0.4×	885 0.7×	1.2k 1.0×	104	6.1k
Louise B. Grochow United States	32	4.0k 1.7×	1.3k 0.9×	1.9k 1.5×	459 0.4×	1.5k 1.2×	59	6.6k
Jean L. Grem United States	41	3.0k 1.3×	1.8k 1.2×	680 0.5×	580 0.5×	970 0.8×	168	5.9k
Kenneth R. Hande United States	46	3.0k 1.3×	2.6k 1.7×	822 0.7×	816 0.7×	1.7k 1.4×	128	6.8k
Jean‐Pierre Armand France	42	3.7k 1.6×	2.6k 1.7×	865 0.7×	515 0.4×	2.1k 1.7×	161	6.9k
Scott Wadler United States	43	4.5k 1.9×	2.0k 1.3×	1.9k 1.5×	975 0.8×	1.9k 1.6×	192	8.1k
Étienne Chatelut France	43	2.6k 1.1×	1.8k 1.1×	637 0.5×	783 0.6×	1.0k 0.9×	234	6.6k
John F. Smyth United Kingdom	52	2.9k 1.2×	3.7k 2.4×	941 0.8×	693 0.6×	544 0.5×	202	8.2k
Arthur Zimmermann Switzerland	53	2.4k 1.0×	2.6k 1.7×	2.0k 1.6×	512 0.4×	685 0.6×	181	7.6k

Countries citing papers authored by Philip S. Schein

Since Specialization

Citations

This map shows the geographic impact of Philip S. Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Schein more than expected).

Fields of papers citing papers by Philip S. Schein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip S. Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Schein. The network helps show where Philip S. Schein may publish in the future.

Co-authorship network of co-authors of Philip S. Schein

This figure shows the co-authorship network connecting the top 25 collaborators of Philip S. Schein. A scholar is included among the top collaborators of Philip S. Schein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip S. Schein. Philip S. Schein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalebic, Thea & Philip S. Schein. (1994). Organic Thiophosphate WR-151327 Suppresses Expression of HIV in Chronically Infected Cells. AIDS Research and Human Retroviruses. 10(6). 727–733. 9 indexed citations

Poplin, Elizabeth, Patricia LoRusso, Jacob J. Lokich, et al.. (1994). Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 33(5). 415–419. 34 indexed citations

Capizzi, Robert L., et al.. (1993). Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy. Cancer. 72(S11). 3495–3501. 47 indexed citations

McCulloch, William, et al.. (1991). New Protective Agents for Bone Marrow in Cancer Therapy. Cancer Investigation. 9(3). 279–287. 17 indexed citations

Manetta, Alberto, et al.. (1991). Analysis of prognostic factors and survival in patients with ovarian cancer treated with second-line hexamethylmelamine (altretamine). Cancer Treatment Reviews. 18. 23–29. 2 indexed citations

Schein, Philip S.. (1990). WR-2721: A Chemotherapy and Radiation-Protective Agent. Cancer Investigation. 8(2). 265–266. 4 indexed citations

Hammer, Charles F., et al.. (1990). New Sugar Mitomycin C Analogues: Preparation, Murine P388 Antitumor Activity, and Leukopenia Induction. Journal of Pharmaceutical Sciences. 79(12). 1105–1108. 2 indexed citations

Coombes, R. Charles, Philip S. Schein, C E Chilvers, et al.. (1990). A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.. Journal of Clinical Oncology. 8(8). 1362–1369. 124 indexed citations

Neefe, John R., et al.. (1989). LACK OF COMMON HAPLOTYPE AMONG FOUR FAMILY MEMBERS WITH LATE‐ONSET KAPOSI'S SARCOMA. International Journal of Immunogenetics. 16(3). 247–250. 2 indexed citations

10.

Treat, Joseph, Paul V. Woolley, James D. Ahlgren, et al.. (1989). Therapy of Advanced Gastric Carcinoma. American Journal of Clinical Oncology. 12(2). 162–168. 3 indexed citations

11.

Tan, K. B., et al.. (1987). Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.. PubMed. 95–8. 19 indexed citations

12.

Schein, Philip S., et al.. (1985). Enhanced Nitrosourea Cytotoxicity in Cell Culture by Sodium Butyrate. Oncology. 42(5). 317–321. 1 indexed citations

13.

España, Pilar, et al.. (1984). Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck. Cancer Chemotherapy and Pharmacology. 12(2). 98–100. 4 indexed citations

14.

Tew, K D, et al.. (1983). Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.. Molecular Pharmacology. 24(2). 324–328. 45 indexed citations

15.

Ahlgren, James D., et al.. (1981). Repair of chloroethylnitrosourea-induced dna lesions in murine bone marrow and l1210 cells. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

16.

Schein, Philip S., et al.. (1978). Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 257–60. 28 indexed citations

17.

Israël, Lucien, et al.. (1978). Immunological and plasma protein changes in cancer patients following a single plasmapheresis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(5). 292–7. 7 indexed citations

18.

Canellos, George P., Vincent T. DeVita, G. Lennard Gold, et al.. (1974). Cyclical Combination Chemotherapy for Advanced Breast Carcinoma. BMJ. 1(5901). 218–220. 83 indexed citations

19.

Schein, Philip S.. (1972). Chemotherapeutic management of the hormone-secreting endocrine malignancies. Cancer. 30(6). 1616–1626. 32 indexed citations

20.

Schein, Philip S., K. G. M. M. Alberti, & D H Williamson. (1971). Effects of Streptozotocin on Carbohydrate and Lipid Metabolism in the Rat. Endocrinology. 89(3). 827–834. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact